Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Holly Williams

Novo Nordisk shares plunge on outlook warning as Mounjaro rival races ahead

Weight loss drug maker Novo Nordisk forecast plunging sales in a surprise after-market announcement on Tuesday (PA) - (PA Wire)

Weight loss drug maker Novo Nordisk has seen shares slump after warning over a sales plunge amid price cuts while a bumper profit haul from its Mounjaro rival Eli Lilly left it trailing behind.

Novo Nordisk – which makes Wegovy and Ozempic – forecast plunging sales in a surprise after-market announcement on Tuesday, which saw the Danish drugmaker’s shares plummet by nearly a fifth on Wednesday.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.